Encompass Health Corporation Common Stock insider trading
EHCfinancial statementsForm 4 filings on EDGAR218 transactions since Nov 3, 2024
From August 6, 2026 to November 3, 2026, 0 insiders at Encompass Health Corporation Common Stock bought $0 of stock in the open market, and 4 sold $26M. Officers and directors accounted for $0 of purchases and $26M of sales. The last reported transaction was an award by Christie Edward M III on October 19, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 19, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $26MAug 6, 2026 – Nov 3, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 3, 2026. Insider data through Nov 3, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
218 transactions from November 3, 2024 to November 3, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Christie Edward M III | Director | award | 221 | $126.63 | $28K | 9,577 | Oct 19, 2026 |
| Oct 19, 2026 | Reidy Christopher R | Director | award | 284 | $126.89 | $36K | 18,081 | Oct 19, 2026 |
| Oct 15, 2026 | Carmichael Greg D | Director | award | 28 | $0.00 | — | 20,377 | Oct 19, 2026 |
| Oct 15, 2026 | Williams Terrance | Director | award | 28 | $0.00 | — | 16,887 | Oct 19, 2026 |
| Oct 15, 2026 | Schlichting Nancy M | Director | award | 38 | $0.00 | — | 23,010 | Oct 19, 2026 |
| Oct 15, 2026 | Herman Joan E | Director | award | 81 | $0.00 | — | 49,724 | Oct 19, 2026 |
| Oct 15, 2026 | Christie Edward M III | Director | award | 11 | $0.00 | — | 9,356 | Oct 19, 2026 |
| Oct 15, 2026 | Reidy Christopher R | Director | award | 20 | $0.00 | — | 17,797 | Oct 19, 2026 |
| Oct 15, 2026 | Hayes Cain A | Director | award | 4 | $0.00 | — | 2,100 | Oct 19, 2026 |
| Oct 15, 2026 | O'Connor Kevin J. | Director | award | 18 | $0.00 | — | 11,600 | Oct 19, 2026 |
| Oct 15, 2026 | Katz Leslye G | Director | award | 81 | $0.00 | — | 49,724 | Oct 19, 2026 |
| Aug 31, 2026 | Price Andrew L | Chief Accounting Officer | open-market sale | 5,211 | $120.93 | $630K | 69,483 | Sep 1, 2026 |
| Aug 31, 2026 | Darby John Patrick | EVP, Gen Counsel & Secretary | option exercise | 4,858 | $35.06 | $170K | 79,899 | Sep 1, 2026 |
| Aug 31, 2026 | Darby John Patrick | EVP, Gen Counsel & Secretary | open-market sale | 4,858 | $121.09 | $588K | 75,041 | Sep 1, 2026 |
| Aug 10, 2026 | Coltharp Douglas E | EVP & Chief Financial Officer | open-market sale | 18,869 | $125.38 | $2M | 50,508 | Aug 11, 2026 |
| Aug 10, 2026 | Tarr Mark J | President & CEO, Director | open-market sale | 171,569 | $125.46 | $22M | 269,393 | Aug 11, 2026 |
| Aug 10, 2026 | Tarr Mark J | President & CEO, Director | open-market sale | 1,579 | $126.06 | $199K | 267,814 | Aug 11, 2026 |
| Aug 10, 2026 | Darby John Patrick | EVP, Gen Counsel & Secretary | open-market sale | 8,906 | $125.95 | $1M | 75,041 | Aug 11, 2026 |
| Jul 16, 2026 | Reidy Christopher R | Director | award | 319 | $112.40 | $36K | 17,777 | Jul 16, 2026 |
| Jul 16, 2026 | Christie Edward M III | Director | award | 248 | $112.43 | $28K | 9,345 | Jul 16, 2026 |
| Jul 15, 2026 | Reidy Christopher R | Director | award | 21 | $0.00 | — | 17,458 | Jul 16, 2026 |
| Jul 15, 2026 | Christie Edward M III | Director | award | 11 | $0.00 | — | 9,097 | Jul 16, 2026 |
| Jul 15, 2026 | Williams Terrance | Director | award | 29 | $0.00 | — | 16,859 | Jul 16, 2026 |
| Jul 15, 2026 | Schlichting Nancy M | Director | award | 40 | $0.00 | — | 22,972 | Jul 16, 2026 |
| Jul 15, 2026 | O'Connor Kevin J. | Director | award | 19 | $0.00 | — | 11,582 | Jul 16, 2026 |
| Jul 15, 2026 | Katz Leslye G | Director | award | 85 | $0.00 | — | 49,643 | Jul 16, 2026 |
| Jul 15, 2026 | Herman Joan E | Director | award | 85 | $0.00 | — | 49,643 | Jul 16, 2026 |
| Jul 15, 2026 | Hayes Cain A | Director | award | 4 | $0.00 | — | 2,096 | Jul 16, 2026 |
| Jul 15, 2026 | Carmichael Greg D | Director | award | 29 | $0.00 | — | 20,349 | Jul 16, 2026 |
| May 15, 2026 | Coltharp Douglas E | EVP & Chief Financial Officer | option exercise | 27,694 | $32.94 | $912K | 97,071 | May 18, 2026 |
| May 15, 2026 | Coltharp Douglas E | EVP & Chief Financial Officer | open-market sale | 27,693 | $106.83 | $3M | 69,378 | May 18, 2026 |
| May 15, 2026 | Coltharp Douglas E | EVP & Chief Financial Officer | open-market sale | 1 | $107.28 | $107 | 69,377 | May 18, 2026 |
| May 11, 2026 | Tuer Patrick William | EVP, Chief Operating Officer | open-market sale | 682 | $104.56 | $71K | 24,755 | May 12, 2026 |
| May 7, 2026 | O'Connor Kevin J. | Director | award | 1,634 | $0.00 | — | 11,563 | May 11, 2026 |
| May 7, 2026 | Christie Edward M III | Director | award | 1,634 | $0.00 | — | 9,086 | May 11, 2026 |
| May 7, 2026 | Reidy Christopher R | Director | award | 1,634 | $0.00 | — | 17,437 | May 11, 2026 |
| May 7, 2026 | Hayes Cain A | Director | award | 1,634 | $0.00 | — | 2,092 | May 11, 2026 |
| May 7, 2026 | Carmichael Greg D | Director | award | 1,634 | $0.00 | — | 20,320 | May 11, 2026 |
| May 7, 2026 | Williams Terrance | Director | award | 1,634 | $0.00 | — | 16,830 | May 11, 2026 |
| May 7, 2026 | Katz Leslye G | Director | award | 1,634 | $0.00 | — | 49,558 | May 11, 2026 |
| May 7, 2026 | Herman Joan E | Director | award | 1,634 | $0.00 | — | 49,558 | May 11, 2026 |
| May 7, 2026 | Schlichting Nancy M | Director | award | 1,634 | $0.00 | — | 22,932 | May 11, 2026 |
| Apr 16, 2026 | Christie Edward M III | Director | award | 261 | $106.17 | $28K | 7,452 | Apr 16, 2026 |
| Apr 16, 2026 | Reidy Christopher R | Director | award | 334 | $106.48 | $36K | 15,803 | Apr 16, 2026 |
| Apr 15, 2026 | Carmichael Greg D | Director | award | 27 | $0.00 | — | 18,686 | Apr 16, 2026 |
| Apr 15, 2026 | Christie Edward M III | Director | award | 9 | $0.00 | — | 7,191 | Apr 16, 2026 |
| Apr 15, 2026 | Hayes Cain A | Director | award | 1 | $0.00 | — | 458 | Apr 16, 2026 |
| Apr 15, 2026 | Herman Joan E | Director | award | 85 | $0.00 | — | 47,924 | Apr 16, 2026 |
| Apr 15, 2026 | Katz Leslye G | Director | award | 85 | $0.00 | — | 47,924 | Apr 16, 2026 |
| Apr 15, 2026 | O'Connor Kevin J. | Director | award | 17 | $0.00 | — | 9,929 | Apr 16, 2026 |
Who the insiders are
Everyone who reported a transaction since November 3, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Tarr Mark J | President & CEO, Director | Aug 10, 2026 | open-market sale | 269,393 | — | $38M (9) | 0 of 9 |
| Coltharp Douglas E | EVP & Chief Financial Officer | Aug 10, 2026 | open-market sale | 50,508 | — | $5M (3) | 0 of 3 |
| Darby John Patrick | EVP, Gen Counsel & Secretary | Aug 31, 2026 | option exercise | 79,899 | — | $2M (2) | 0 of 2 |
| Fay Edmund | Sr. Vice Pres. and Treasurer | Mar 9, 2026 | gift | 86,325 | — | $1M (1) | 0 of 1 |
| Price Andrew L | Chief Accounting Officer | Aug 31, 2026 | open-market sale | 69,483 | — | $630K (1) | 0 of 1 |
| Tuer Patrick William | EVP, Chief Operating Officer | May 11, 2026 | open-market sale | 24,755 | — | $373K (2) | 0 of 2 |
| Christie Edward M III | Director | Oct 19, 2026 | award | 9,577 | — | — | — |
| Reidy Christopher R | Director | Oct 19, 2026 | award | 18,081 | — | — | — |
| Charbonneau Elissa Joy | Chief Medical Officer | Feb 28, 2026 | tax withholding | 17,644 | — | — | — |
| Carmichael Greg D | Director | Oct 15, 2026 | award | 20,377 | — | — | — |
| Williams Terrance | Director | Oct 15, 2026 | award | 16,887 | — | — | — |
| Schlichting Nancy M | Director | Oct 15, 2026 | award | 23,010 | — | — | — |
| Herman Joan E | Director | Oct 15, 2026 | award | 49,724 | — | — | — |
| O'Connor Kevin J. | Director | Oct 15, 2026 | award | 11,600 | — | — | — |
| Katz Leslye G | Director | Oct 15, 2026 | award | 49,724 | — | — | — |
| Hayes Cain A | Director | Oct 15, 2026 | award | 2,100 | — | — | — |
| Maryland Patricia Anne | Director | Jul 15, 2025 | award | 14,764 | — | — | — |
Questions
Are Encompass Health Corporation Common Stock insiders buying or selling?
Over the twelve months to November 3, 2026, 6 insiders at Encompass Health Corporation Common Stock sold $48M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $48M. Only open-market purchases and sales are counted.
Who sold the most Encompass Health Corporation Common Stock stock in the last year?
Tarr Mark J (President & CEO, Director) sold $38M in 9 open-market sales over the twelve months to November 3, 2026.
Do Encompass Health Corporation Common Stock executives sell under 10b5-1 plans?
0 of the 18 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Encompass Health Corporation Common Stock
- Encompass Health Corporation Common Stock financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.